Form 4: Cero Therapeutics Holdings Director Brian Atwood Reports Stock Conversion and Option Forfeiture
SEC Form 4 Filing
Director Brian Atwood converted Series A Preferred Stock into common stock and forfeited employee stock options following his resignation as CEO.
Summary
- On September 25, 2024, Brian Atwood, a director of Cero Therapeutics Holdings, converted 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock.
- The conversion was based on a formula where each share of Series A Preferred Stock, with a stated value of $1,000, is convertible into common stock at a conversion price of $1.00, resulting in 19,320 shares of common stock per $1,000 of preferred stock due to adjustments in the terms.
- Atwood also reported the forfeiture of 1,331,813 employee stock options with exercise prices of $5.28 and $1.77, respectively, in connection with his resignation as Chief Executive Officer.
- Following these transactions, Atwood directly owns no derivative securities and indirectly through the Atwood-Edminster Trust dtd 4-2-2000, owns 19,607,313 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. The conversion of preferred stock to common stock is neither inherently positive nor negative, and the option forfeiture is a consequence of a change in employment.
Negatives
- Brian Atwood forfeited 1,331,813 employee stock options as a result of his resignation as CEO.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Brian Atwood | TBD | Implied as of 09/30/2024 | Resignation |
Stakeholder Impact
- The conversion of preferred stock to common stock may slightly dilute existing shareholders' equity.
- The resignation of the CEO could lead to uncertainty among employees and investors until a replacement is named.
Key Dates
| Date | Description |
|---|---|
| 4-2-2000 | Date of the Atwood-Edminster Trust |
| 09/25/2024 | Date of Series A Preferred Stock conversion to Common Stock |
| 09/30/2024 | Date of Stock Option (Right to Buy) forfeiture |
| 10/02/2024 | Date of signature on the Form 4 filing |
| 12/27/2030 | Expiration date of forfeited Stock Option (Right to Buy) |
| 03/24/2034 | Expiration date of forfeited Stock Option (Right to Buy) |
Keywords
Form 4, Beneficial Ownership, Series A Preferred Stock, Common Stock, Stock Options, Conversion, Forfeiture, Director, CEO, CERO, Atwood
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.